Your browser doesn't support javascript.
loading
Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study.
Huang, Rui; Fan, Jian-Gao; Shi, Jun-Ping; Mao, Yi-Min; Wang, Bing-Yuan; Zhao, Jing-Min; Lu, Lun Gen; Zhong, Bi-Hui; Zou, Zheng-Sheng; Xu, You-Qing; Ye, Yi-Nong; Liu, Longgen; Lin, Lian-Jie; Rao, Huiying; Wei, Lai.
Afiliação
  • Huang R; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China.
  • Fan JG; Department of Hepatology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Shi JP; Department of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
  • Mao YM; Department of Digestive, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang BY; Department of Digestive, The First Hospital of China Medical University, Shenyang, China.
  • Zhao JM; Department of Pathology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Lu LG; Department of Hepatology, The First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhong BH; Department of Digestive, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Zou ZS; Department of Pathology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Xu YQ; Department of Digestive, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Ye YN; Department of Infectious Disease, The First Hospital of Fushan, Fushan, China.
  • Liu L; Department of Hepatology, Third People's Hospital of Changzhou, Changzhou, China.
  • Lin LJ; Department of Digestive, Shengjing Hospital of China Medical University, Shenyang, China.
  • Rao H; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China raohuiying@pkuph.edu.cn weilai@mail.tsinghua.e
  • Wei L; Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China raohuiying@pkuph.edu.cn weilai@mail.tsinghua.edu.cn.
BMJ Open ; 13(6): e062131, 2023 06 20.
Article em En | MEDLINE | ID: mdl-37339833
ABSTRACT

OBJECTIVES:

Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease worldwide. However, treatment of NAFLD is potentially influenced by psychological conditions. Using the simplified version of the University of Rhode Island Change Assessment (URICA-SV) scale, this study aimed to evaluate the stage of psychological change as a prerequisite to refining implementation strategies for psychological change.

DESIGN:

A multicentre cross-sectional survey.

SETTING:

Ninety hospitals in China.

PARTICIPANTS:

5181 patients with NAFLD were included in this study. OUTCOME

MEASURES:

All patients completed the URICA-SV questionnaire and were assigned to one of the three stages of change (precontemplation, contemplation or action) according to their readiness scores. A stepwise multivariate logistic regression analysis was used to identify independent factors associated with the stage of psychological change.

RESULTS:

A total of 4832 (93.3%) patients were included in the precontemplation stage and only 349 (6.7%) considered making a change or preparing to make one. There were significant differences in gender (Cohen's d=0.039, p=0.005), age (Cohen's d=-0.327, p<0.001), waist circumference (Cohen's d=0.143, p=0.003), alanine transaminase (Cohen's d=0.347, p=0.001), triglyceride (Cohen's d=0.351, p=0.002), body mass index (BMI; Cohen's d=0.056, p<0.001), proportion of hyperlipidaemia (Cohen's d=0.068, p<0.001) and cardiovascular disease (Cohen's d=0.032, p=0.029), therapeutic regimen (Cohen's d=0.136, p<0.001), and Chronic Liver Disease Questionnaire-Non-Alcoholic Fatty Liver Disease overall score (Cohen's d=-0.420, p<0.001) between patients with NAFLD in the precontemplation stage and those in the contemplation/action stage. Logistic regression identified BMI (HR 0.659, 95% CI 0.469 to 0.928, p=0.017), cardiovascular disease (HR 2.161, 95% CI 1.089 to 4.287, p=0.027) and triglyceride (HR 0.751, 95% CI 0.591 to 0.955, p=0.020) as independent factors predicting psychological change.

CONCLUSIONS:

The results demonstrated that very few patients with NAFLD presented psychological condition in the stage of action. Psychological condition was found to be significantly related to BMI, cardiovascular disease and triglyceride factors. Integrated diversity considerations for evaluating psychological change are necessary.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hepatopatia Gordurosa não Alcoólica / Doenças Metabólicas Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hepatopatia Gordurosa não Alcoólica / Doenças Metabólicas Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article